๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Impact of age on tolerance of chemoradiation and survival for patients with local regionally advanced cervical cancer: A pooled analysis of Gynecologic Oncology Group (GOG) phase III trials

โœ Scribed by Slaughter, K.N.; Java, J.; Stehman, F.B.; Rose, P.G.; Moore, K.N.; DiSilvestro, P.A.

Book ID
126539644
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
156 KB
Volume
133
Category
Article
ISSN
0090-8258

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Impact on survival of 12 versus 3 monthl
Impact on survival of 12 versus 3 monthly cycles of paclitaxel (175 mg/m2) administered to patients with advanced ovarian cancer who attained a complete response to primary platinum-paclitaxel: Follow-up of a Southwest Oncology Group and Gynecologic Oncology Group phase 3 trial
โœ Maurie Markman; P.Y. Liu; James Moon; Bradley J. Monk; Larry Copeland; Sharon Wi ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 307 KB
P.39 Docetaxel plus epirubicin (DE) vs d
P.39 Docetaxel plus epirubicin (DE) vs docetaxel plus capecitabine (DC) as 1st line treatment in patients with locally advanced and metastatic breast cancer: a subgroup analysis for elderly patients of a multicenter randomized phase III trial from the Hellenic Oncology Research Group (HORG)
โœ Vamvakas, L.; Karampeazis, A.; Ardavanis, A.; Souglakos, I.; Kalbakis, K.; Varda ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 57 KB
P.40 Oral vinorelbine and gemcitabine (o
P.40 Oral vinorelbine and gemcitabine (oVG) versus docetaxel and gemcitabine (DG) as first-line treatment of patients with advanced non-small cell lung cancer (NSCLC): a subgroup analysis for elderly patients of a phase III randomized trial from the Hellenic Oncology Research Group (HORG)
โœ Vamvakas, L.; Karampeazis, A.; Agelaki, S.; Agelidou, A.; Kotsakis, A.; Kakolyri ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 57 KB